NDC 54925-032 - TRI OTIC
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 54925-032
- Package NDCs from labels
- 54925-032-75, 54925-032-15, 54925-032-10, 54925-032-45, 54925-032-25, 54925-032-40
- Manufacturer
- Med-Pharmex, Inc
- Effective date
- 2023-07-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| TRI OTIC - Med-Pharmex, Inc | Med-Pharmex, Inc | 2023-07-14 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| BETAMETHASONE VALERATE | ACTIVE INGREDIENT | 9IFA5XM7R2 | TRI OTIC (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE ) OINTMENT [MED-PHARMEX, INC] | 2 | |
| CLOTRIMAZOLE | ACTIVE INGREDIENT | G07GZ97H65 | TRI OTIC (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE ) OINTMENT [MED-PHARMEX, INC] | 2 | |
| GENTAMICIN SULFATE | ACTIVE INGREDIENT | 8X7386QRLV | TRI OTIC (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE ) OINTMENT [MED-PHARMEX, INC] | 2 | |
| BETAMETHASONE | ACTIVE MOIETY | 9842X06Q6M | TRI OTIC (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE ) OINTMENT [MED-PHARMEX, INC] | 2 | |
| CLOTRIMAZOLE | ACTIVE MOIETY | G07GZ97H65 | TRI OTIC (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE ) OINTMENT [MED-PHARMEX, INC] | 2 | |
| GENTAMICIN | ACTIVE MOIETY | T6Z9V48IKG | TRI OTIC (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE ) OINTMENT [MED-PHARMEX, INC] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CLOTRIMAZOLE | CLOTRIMAZOLE | Rugby Laboratories, Inc. | 2c60e631-5930-4420-886d-eb1990c720b6 | 2026-05-11 | Warnings | G07GZ97H65 |
| clotrimazole | CLOTRIMAZOLE | A-S Medication Solutions | c0f58a0d-a304-41f9-bbdf-c2e488230cf0 | 2026-05-11 | Warnings | G07GZ97H65 |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Cardinal Health 107, LLC | 5113bfad-42ca-4bb8-9343-0b08c6cd03f0 | 2026-05-08 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Clotrimazole | CLOTRIMAZOLE | Akron Pharma Inc | 692d7e0f-50d4-4abb-8c74-36bc98064fe7 | 2026-05-05 | Warnings | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | KJD Pharma Private Limited | 5115f8e3-5668-5207-e063-6394a90a7650 | 2026-05-05 | Warnings | G07GZ97H65 |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Preferred Pharmaceuticals Inc. | 5ac8ea7a-ee89-49f5-8d30-6dbb56503d94 | 2026-05-05 | Warnings, Adverse reactions | 8X7386QRLV |
| Clotrimazole Topical Solution USP, 1% | CLOTRIMAZOLE TOPICAL SOLUTION USP, 1% | ScieGen Pharmaceuticals, Inc | 15368c2a-572f-41fb-a3a1-7b1eb842faa8 | 2026-04-30 | Warnings, Adverse reactions | G07GZ97H65 |
| FifthPulse Clotrimazole Antifungal | CLOTRIMAZOLE | WeCare Products LLC | 9f5ea297-5a25-42cc-bd47-4159108b0023 | 2026-04-27 | Warnings | G07GZ97H65 |
| SimplyVital Antifungal Clotrimazole | CLOTRIMAZOLE | Alpha Plants Inc | 44881106-3ab4-4103-9c48-1da435ab5b13 | 2026-04-16 | Warnings | G07GZ97H65 |
| Clotrimazole Topical Solution USP, 1% | CLOTRIMAZOLE TOPICAL SOLUTION USP, 1% | Allegis Holdings, LLC | 529bb597-b291-42fb-b45f-744a55df64f1 | 2026-04-09 | Warnings, Adverse reactions | G07GZ97H65 |
| RoyceDerm Tinea ANTIFUNGAL .soap. | CLOTRIMAZOLE 1% | RoyceDerm LLC | 4e889f2b-9ea1-b1a6-e063-6394a90a4654 | 2026-04-03 | Warnings | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | Preferred Pharmaceuticals Inc. | 70e1efac-1738-43db-b19c-bbe02810b6e7 | 2026-04-01 | Warnings | G07GZ97H65 |
| Clotrimazole and Betamethasone Dipropionate | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | Sportpharm LLC | 313dde2e-fb82-4786-988b-565d3e003c37 | 2026-04-01 | Warnings, Adverse reactions | G07GZ97H65 |
| RUGBY ANTIFUNGAL CLOTRIMAZOLE | CLOTRIMAZOLE | Preferred Pharmaceuticals Inc. | caba588a-13df-4035-ac41-6b4ec90cd88d | 2026-04-01 | Warnings | G07GZ97H65 |
| Clotrimazole and Betamethasone Dipropionate | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | Preferred Pharmaceuticals Inc. | 196e24fc-3315-4366-ad40-51b7ea54b211 | 2026-04-01 | Warnings, Adverse reactions | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | Preferred Pharmaceuticals Inc. | 80d67df3-843d-47bb-85a2-d2f26a824336 | 2026-03-31 | Warnings | G07GZ97H65 |
| RoyceDerm Antifungal Bar | CLOTRIMAZOLE | RoyceDerm LLC | 3abdc4a8-58dd-5bd0-e063-6294a90a1bca | 2026-03-31 | Warnings | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | Preferred Pharmaceuticals, Inc. | 624827d6-dbf8-4f3d-a8c0-c92474cad7de | 2026-03-31 | Warnings | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | Preferred Pharmaceuticals Inc. | fd010006-f646-46ed-841a-9f247b19e397 | 2026-03-31 | Warnings | G07GZ97H65 |
| Lasolex Liquid Solution | CLOTRIMAZOLE 1% | PureTek Corporation | 4dc9e64d-8235-b218-e063-6394a90a0157 | 2026-03-24 | Warnings | G07GZ97H65 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.